Acid pill or liquid: which works better after Weight-Loss surgery?
NCT ID NCT05320796
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the body absorbs esomeprazole (a stomach acid reducer) when taken as a tablet or dissolved in water, in people who had gastric bypass surgery a year ago. Fifty participants will have a small device placed in their stomach pouch to measure acid levels, and blood samples will be taken to check drug levels. The goal is to see which form works better to control acid and prevent ulcers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Esomeprazole (a proton pump inhibitor that reduces stomach acid)
What this could lead to
If it works, this could help doctors choose the best way to give acid-reducing medicine after gastric bypass surgery.
What could go wrong
This is a small, early pilot study with only 50 participants, so results may not apply to everyone. It does not test long-term benefits or risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Spital Limmattal
RECRUITINGSchlieren, Schlieren, 8952, Switzerland
Contact Email: •••••@•••••